Rare
lephants
Screener
Toggle theme
Harrow, Inc.
HROW
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2023
FY2022
FY2021
FY2019
FY2018
Total Cash from Operations:
$3.9M
Line Item
Value
% of Total
Capital Expenditures
$613.4K
15.8%
Other Financing
$336.6K
8.6%
Working Capital
$2.9M
75.6%
Net Cash Flow
$0
0.0%
Download CSV
